Risedronic acid. NE 58095, risedronate sodium, Actonel.
D000368:Aged; D000818:Animals; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control; D051381:Rats; D000068296:Risedronic Acid
D015507:Drugs, Investigational; D000068296:Risedronic Acid; D012968:Etidronic Acid